Back to mobile site

Minerva Neurosciences to Present at Upcoming Investor Conferences in June

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. BJ
9. OSIS
10. FMG:AU

May 28, 2015 8:01 AM EDT

WALTHAM, Mass., May 28, 2015 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central nervous system (CNS) diseases and disorders, today announced that it will participate in the following upcoming investor conferences:

Event: Jefferies 2015 Global Healthcare Conference
Date / Time: Thursday, June 4, 2015 at 11:00 AM (EDT)
Location: New York, NY
   
Event: JMP Securities Life Sciences Conference 2015
Date / Time: Tuesday, June 23, 2015 at 3:00 PM (EDT)
Location: The St. Regis New York, New York, NY

Live audio webcasts will be available online from the investor relations section of the company's website at http://ir.minervaneurosciences.com. A replay of the presentation will be posted on the Minerva website approximately one hour after the events and will be available for the following 30 days.

About Minerva Neurosciences:

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates to treat CNS diseases. Minerva is developing proprietary compounds, including its lead program MIN-101 in development for the treatment of schizophrenia, MIN-202 (JNJ-922) in development for primary and comorbid insomnia, MIN-117 in development for the treatment of major depressive disorder and MIN-301 in development for the treatment of Parkinson's disease. Minerva's common stock is listed on the NASDAQ Global Market where it trades under the symbol "NERV". For more information, please visit: www.minervaneurosciences.com/.

CONTACT: Media Contact:
         Bill Berry
         Berry & Company Public Relations
         212-253-8881
         [email protected]

         Investor Contact:
         Stephanie Ascher
         Stern Investor Relations
         212-362-1200
         [email protected]

Source: Minerva Neurosciences, Inc

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Press Releases

Related Entities

Jefferies & Co, JMP Securities